About a quarter of patients (26.3%) had at least two co-morbidities. Moxifloxacin therapy was started within a week of the appearance of acute symptoms in most patients (83.5%); the mean interval ...
Objective: To assess the efficacy, safety and tolerability of oral moxifloxacin in outpatients with respiratory tract infections treated in general practices in Germany with the focus on community ...